Search
Now showing items 1-1 of 1
Cost Effectiveness of PCSK9 Inhibitors for the Secondary Prevention of Cardiovascular Disease in Ireland: Considerations given to Population Heterogeneity
(Trinity College Dublin. School of Medicine. Discipline of Pharmacology & Therapeutics, 2020)